Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-N-3446

Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted)

Documents

Comments

Description

Open

Documents

Type	Title	Posted	Comments	Status
Notice	Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) FR Doc: 2026-07368	Apr 16, 2026	--	--

Keywords

CBER

FRDTS # 2025-65

Notice of Approval of Product Under Voucher

Rare Pediatric Disease Priority Review Voucher

AREXVY

Respiratory Syncytial Virus Vaccine Adjuvanted

OPEN

Data from Regulations.gov